BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 38397196)

  • 1. Immunogenetic Aspects of Sarcopenic Obesity.
    Mazurkiewicz Ł; Czernikiewicz K; Grygiel-Górniak B
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review.
    Evans K; Abdelhafiz D; Abdelhafiz AH
    Postgrad Med; 2021 Nov; 133(8):831-842. PubMed ID: 34126036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.
    Batsis JA; Mackenzie TA; Jones JD; Lopez-Jimenez F; Bartels SJ
    Clin Nutr; 2016 Dec; 35(6):1472-1483. PubMed ID: 27091774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.
    Kalinkovich A; Livshits G
    Ageing Res Rev; 2017 May; 35():200-221. PubMed ID: 27702700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention.
    Li CW; Yu K; Shyh-Chang N; Li GX; Jiang LJ; Yu SL; Xu LY; Liu RJ; Guo ZJ; Xie HY; Li RR; Ying J; Li K; Li DJ
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):586-600. PubMed ID: 30969486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).
    Tan S; Scherag A; Janssen OE; Hahn S; Lahner H; Dietz T; Scherag S; Grallert H; Vogel CI; Kimmig R; Illig T; Mann K; Hebebrand J; Hinney A
    BMC Med Genet; 2010 Jan; 11():12. PubMed ID: 20092643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of skeletal muscle mass and fat mass on the metabolic and inflammatory profile in sarcopenic and non-sarcopenic overfat elderly.
    Rossi FE; Lira FS; Silva BSA; Freire APCF; Ramos EMC; Gobbo LA
    Aging Clin Exp Res; 2019 May; 31(5):629-635. PubMed ID: 30178443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.
    Donini LM; Busetto L; Bischoff SC; Cederholm T; Ballesteros-Pomar MD; Batsis JA; Bauer JM; Boirie Y; Cruz-Jentoft AJ; Dicker D; Frara S; Frühbeck G; Genton L; Gepner Y; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Nyulasi I; Parrinello E; Poggiogalle E; Prado CM; Salvador J; Rolland Y; Santini F; Serlie MJ; Shi H; Sieber CC; Siervo M; Vettor R; Villareal DT; Volkert D; Yu J; Zamboni M; Barazzoni R
    Obes Facts; 2022; 15(3):321-335. PubMed ID: 35196654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Relation to Sarcopenia and Sarcopenic Obesity among Older Adults Living with Chronic Comorbidities: Results from the National Health and Nutrition Examination Survey 1999-2006.
    Karanth SD; Washington C; Cheng TD; Zhou D; Leeuwenburgh C; Braithwaite D; Zhang D
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease.
    Kim TN; Choi KM
    J Cell Biochem; 2015 Jul; 116(7):1171-8. PubMed ID: 25545054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between obesity candidate gene polymorphisms (fat mass and obesity-associated (FTO), melanocortin-4 receptor (MC4R), leptin (LEP) and leptin receptor (LEPR)) and dietary intake in pregnant women.
    Martins MC; Trujillo J; Freitas-Vilela AA; Farias DR; Rosado EL; Struchiner CJ; Kac G
    Br J Nutr; 2018 Aug; 120(4):454-463. PubMed ID: 29893663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
    Luo X; Cai B; Jin W
    Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations.
    Cauchi S; Stutzmann F; Cavalcanti-Proença C; Durand E; Pouta A; Hartikainen AL; Marre M; Vol S; Tammelin T; Laitinen J; Gonzalez-Izquierdo A; Blakemore AI; Elliott P; Meyre D; Balkau B; Järvelin MR; Froguel P
    J Mol Med (Berl); 2009 May; 87(5):537-46. PubMed ID: 19255736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Impact of Common Polymorphisms of the FTO and MC4R Genes with the Risk of Severe Obesity in Saudi Arabian Population.
    Cyrus C; Ismail MH; Chathoth S; Vatte C; Hasen M; Al Ali A
    Genet Test Mol Biomarkers; 2018 Mar; 22(3):170-177. PubMed ID: 29466028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
    McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
    BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of FTO Gene associated with lean mass in a Meta-Analysis of Genome-Wide Association Studies.
    Ran S; Jiang ZX; He X; Liu Y; Zhang YX; Zhang L; Pei YF; Zhang M; Hai R; Gu GS; Liu BL; Tian Q; Zhang YH; Wang JY; Deng HW
    Sci Rep; 2020 Mar; 10(1):5057. PubMed ID: 32193455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the FTO and ADRB2 genes with body composition and fat distribution in obese women.
    Rauhio A; Uusi-Rasi K; Nikkari ST; Kannus P; Sievänen H; Kunnas T
    Maturitas; 2013 Oct; 76(2):165-71. PubMed ID: 23911093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.
    Donini LM; Busetto L; Bischoff SC; Cederholm T; Ballesteros-Pomar MD; Batsis JA; Bauer JM; Boirie Y; Cruz-Jentoft AJ; Dicker D; Frara S; Frühbeck G; Genton L; Gepner Y; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Nyulasi I; Parrinello E; Poggiogalle E; Prado CM; Salvador J; Rolland Y; Santini F; Serlie MJ; Shi H; Sieber CC; Siervo M; Vettor R; Villareal DT; Volkert D; Yu J; Zamboni M; Barazzoni R
    Clin Nutr; 2022 Apr; 41(4):990-1000. PubMed ID: 35227529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study.
    Cesari M; Kritchevsky SB; Baumgartner RN; Atkinson HH; Penninx BW; Lenchik L; Palla SL; Ambrosius WT; Tracy RP; Pahor M
    Am J Clin Nutr; 2005 Aug; 82(2):428-34. PubMed ID: 16087989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.